Are you Dr. Vince?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10103 Metcalf Ave.
Overland Park, KS 66212Phone+1 913-696-1601Fax+1 913-696-1640
Summary
- Dr. Bradley Vince, DO is a psychiatrist in Overland Park, Kansas. He is currently licensed to practice medicine in Kansas.
Education & Training
- University of Kansas School of MedicineResidency, Psychiatry, 1998 - 2002
- Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1998
Certifications & Licensure
- KS State License 1999 - 2025
Clinical Trials
- Normative Data of Brain Network Activation in Adolescents and Young Adults Start of enrollment: 2011 Oct 01
- Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers Start of enrollment: 2013 Nov 01
- Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects Start of enrollment: 2012 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsA randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.Jermaine D. Jones, Shanna Babalonis, Ronald Marcus, Bradley Vince, Debra Kelsh
Addiction Biology. 2020-07-01 - 11 citationsAbuse potential of mirogabalin in recreational polydrug users.Jeanne Mendell, Naama Levy-Cooperman, Ed Sellers, Bradley Vince, Debra Kelsh
Therapeutic Advances in Drug Safety. 2019-04-05 - 9 citationsAbuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled TrialSanjeev Pathak, Bradley Vince, Debra Kelsh, Megan J. Shram, Beatrice Setnik
Journal of Clinical Pharmacology. 2019-02-01
Press Mentions
- Dr. Vince Clinical Research Launches New Solution for Organ Impairment StudiesDecember 14th, 2023